๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Glucose anhydrous - Medicines in Ireland

14 authorised products containing Glucose anhydrous, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 14 authorised medicines
MedicineActive substanceLicence holderStatus
Dianeal PD4 Glucose 1.36 % w/v (13.6 mg/ml), Solution for peritoneal dialysis
PA25288/001/001
Glucose anhydrous, Glucose monohydrate, Sodium chloride, Sodium lactate, Calcium chloride dihydrate ph. eur. Vantive Belgium SRL Not marketed
Dianeal PD4 Glucose 2.27 % w/v (22.7 mg/ml), Solution for peritoneal dialysis
PA25288/001/002
Glucose anhydrous, Glucose monohydrate, Sodium chloride, Sodium lactate, Calcium chloride dihydrate Vantive Belgium SRL Not marketed
Dianeal PD4 Glucose 3.86 % w/v (38.6 mg/ml), Solution for peritoneal dialysis
PA25288/001/003
Glucose anhydrous, Glucose monohydrate, Sodium chloride, Sodium lactate, Calcium chloride dihydrate Vantive Belgium SRL Not marketed
Glucose 10% w/v Solution for Infusion
PA2059/040/005
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Glucose 10% w/v Solution for Infusion
PA2059/040/006
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Glucose 10% w/v Solution for Infusion
PA2059/040/007
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Glucose 10% w/v Solution for Infusion
PA2059/040/008
Glucose anhydrous Fresenius Kabi Deutschland GmbH Marketed
Glucose 10% w/v Solution for Infusion
PA2059/040/010
Glucose anhydrous Fresenius Kabi Deutschland GmbH Marketed
Glucose 5% w/v Solution for Infusion
PA2059/040/001
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Glucose 5% w/v Solution for Infusion
PA2059/040/003
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Glucose 5% w/v Solution for Infusion
PA2059/040/004
Glucose anhydrous Fresenius Kabi Deutschland GmbH Marketed
Glucose 5% w/v Solution for Infusion
PA2059/040/009
Glucose anhydrous Fresenius Kabi Deutschland GmbH Marketed
Glucose 5% w/v, Solution for Infusion
PA2059/040/002
Glucose anhydrous Fresenius Kabi Deutschland GmbH Not marketed
Potassium Chloride 0.15% w/v, Sodium Chloride 0.18% w/v, Glucose 4% w/v Solution for Infusion
PA2299/001/002
Potassium chloride, Sodium chloride, Glucose anhydrous Baxter Holding B.V. Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.